[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353428-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-353428-en":135},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","theragenerative-nanomaterials-integrating-therapy-regeneration-and-diagnosis-navigating-the-shared-pathways-between-tissue-repair-and-malignancy","Theragenerative Nanomaterials: Integrating Therapy, Regeneration, and Diagnosis - Navigating the Shared Pathways Between Tissue Repair and Malignancy","","Nanotechnology is reshaping regenerative medicine and oncology by enabling programmable nanomaterials that modulate biological responses. Yet tissue repair and cancer rely on shared signaling pathways, creating a critical safety challenge: pro-regenerative cues may also activate malignant programs. This review presents the “theragenerative” paradigm, covering therapeutic, regenerative, and diagnostic functions. It evaluates dual roles, highlights translational risks and hurdles, and proposes context-aware platforms balancing healing with anti-tumor effects while reducing oncogenic potential.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/theragenerative-nanomaterials-integrating-therapy-regeneration-and-diagnosis-navigating-the-shared-pathways-between-tissue-repair-and-malignancy/353428/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/theragenerative-nanomaterials-integrating-therapy-regeneration-and-diagnosis-navigating-the-shared-pathways-between-tissue-repair-and-malignancy/353428.png","ImageObject",300,407,{"name":42,"@type":43},"CatatanPagi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What does the “theragenerative” paradigm mean in this review?","Question",{"text":63,"@type":64},"It describes nanomaterial platforms that simultaneously integrate therapeutic (anti-cancer), regenerative (tissue repair), and diagnostic (real-time monitoring) functions at the regenerative–oncology interface.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why is there a safety concern when promoting tissue repair using nanomaterials?",{"text":68,"@type":64},"Because many pro-regenerative stimuli act through signaling pathways that are also used by cancer, so activation can unintentionally promote malignant transformation.",{"name":70,"@type":61,"acceptedAnswer":71},"Which shared pathways are highlighted as having dual-edged effects?",{"text":72,"@type":64},"The review emphasizes Wnt/β-catenin, MAPK/ERK, Notch, Hedgehog, and YAP/TAZ, noting that pathway activation can support regeneration while potentially driving tumor-related processes.",{"name":74,"@type":61,"acceptedAnswer":75},"What main requirements are suggested for successful clinical adoption?",{"text":76,"@type":64},"Clinical translation requires selective modulation of signaling pathways, restricted activity to defined sites, and precise control of timing, along with addressing long-term safety, manufacturing, regulation, and optimization challenges.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},353428,1790389467,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,131],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":128,"slug":130},10,"Lifestyle","lifestyle",{"id":132,"doc_module":4,"doc_module_name":25,"category_name":133,"show_sort_weight":101,"slug":134},19,"General","general",{"code":4,"msg":86,"data":136},{"doc_id":83,"user_id":137,"nickname":42,"user_avatar":138,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":144,"language":145,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":146,"faqs":147,"seo_title":148,"seo_description":12,"update_tm":149,"read_time":150,"preview_page_count":116,"preview_urls":151},962090894170,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","International Journal of Nanomedicine  \nOpen Access Full Text Article REVIEW  \nTheragenerative Nanomaterials: Integrating Therapy, Regeneration, and Diagnosis—Navigating the Shared Pathways Between Tissue Repair and Malignancy  \nPardis Yousefi Talouki 1 , Reyhaneh Tamimi2 , Nazanin Jafaripour 3  \n1Department of Biomedical Engineering, QaS. C., Islamic Azad University, Qaemshahr, Iran; 2Department of Biomedical Engineering, Amirkabir University of Technology, Tehran, Iran; 3Institute of Biomaterials, University of Tehran & Tehran University of Medical Sciences (IBUTUMS), Tehran, Iran  \nCorrespondence: Pardis Yousefi Talouki; Reyhaneh Tamimi, Email [pardisyousefi721@gmail.com](pardisyousefi721@gmail.com); [reyhaneh.tamimi@aut.ac.ir](reyhaneh.tamimi@aut.ac.ir)  \nBackground: Nanotechnology convergence with regenerative medicine and oncology creates opportunities and challenges. Nanomaterials can be programmed to modulate biological responses, yet tissue repair and cancer share fundamental signaling pathways—including Wnt/β-catenin, Mitogen-Activated Protein Kinase (MAPK)/ Extracellular Signal-Regulated Kinase (ERK), Notch, and Hedgehog—raising a  \ncritical concern: pro-regenerative stimuli may inadvertently activate malignant programs. This review introduces the “theragenerative”paradigm, defined as nanomaterial platforms that concurrently integrate therapeutic (anti-cancer), regenerative (tissue repair), and diagnostic (real-time monitoring) functions. We examine the dual role of nanomaterials at the regenerative–oncology interface and propose context-aware platforms that dynamically balance healing and anti-tumor effects while minimizing oncogenic risk. Unlike conventional reviews that separately address nanocarriers for drug delivery or scaffolds for tissue engineering, this review is explicitly organized around the central question of how to establish safe boundaries between regenerative signals and tumor-promoting pathways—a distinction that defines the theragenerative framework.  \nMethods: We critically reviewed the literature on nanostructured scaffolds, cell-instructive surfaces, stimuli-responsive nanocarriers (pH, redox, enzyme, hypoxia), and biomimetic cell membrane-coated platforms, synthesizing findings from both foundational and recent studies. Studies on Extracellular Matrix (ECM) mimicry, tumor microenvironment-responsive drug delivery, and theragenerative systems were analyzed. Key shared pathways and translational challenges (safety, scalability, regulation, AI) were assessed. Results: Nanostructured scaffolds guide stem cell behavior and promote tissue repair by recreating ECM cues. Smart nanocarriers exploiting TME triggers (acidic pH, high glutathione, overexpressed Matrix Metalloproteinase (MMPs)) achieve precise drug delivery with reduced off-target effects. Theragenerative platforms combine therapy, regeneration, and diagnostics for real-time monitoring. However, the shared pathways—particularly Wnt/β-catenin, Notch, Hedgehog, and YAP/TAZ—pose a dual-edged risk: their activation promotes regeneration but may inadvertently drive malignant transformation, while their inhibition suppresses tumors but can impair tissue repair. This necessitates precise, context-dependent nanoparticle programming to navigate this therapeutic dilemma. Major hurdles include long-term genotoxicity, immunogenicity, manufacturing scalability, regulatory pathways for combination products, and AI-driven optimization.  \nConclusion: Smart nanomaterials that sense their surroundings can operate at the crossroads of regenerative medicine and oncology. They either promote tissue repair or trigger tumor cell death while sparing healthy tissues. Successful clinical adoption requires a system that selectively modulates signaling pathways, restricts activity to defined sites, and controls timing precisely. This strategy could revolutionize personalized treatment for patients who simultaneously suffer from cancer and tissue defects.  \nKeywords: ","cbCaib8FCYqTq9Ts","https://ap.wps.com/l/cbCaib8FCYqTq9Ts","pdf",6754625,71,"English","# Background\n## Shared regenerative–oncology signaling pathways\n# Theragenerative Paradigm\n## Core definition and organizing question\n# Methods\n## Literature review scope and systems analyzed\n# Results\n## Regenerative scaffolds, stimuli-responsive carriers, and monitoring\n## Dual-edged risks and key pathways\n# Conclusion\n## Context-dependent nanoparticle programming and clinical outlook","[{\"question\":\"What does the “theragenerative” paradigm mean in this review?\",\"answer\":\"It describes nanomaterial platforms that simultaneously integrate therapeutic (anti-cancer), regenerative (tissue repair), and diagnostic (real-time monitoring) functions at the regenerative–oncology interface.\"},{\"question\":\"Why is there a safety concern when promoting tissue repair using nanomaterials?\",\"answer\":\"Because many pro-regenerative stimuli act through signaling pathways that are also used by cancer, so activation can unintentionally promote malignant transformation.\"},{\"question\":\"Which shared pathways are highlighted as having dual-edged effects?\",\"answer\":\"The review emphasizes Wnt/β-catenin, MAPK/ERK, Notch, Hedgehog, and YAP/TAZ, noting that pathway activation can support regeneration while potentially driving tumor-related processes.\"},{\"question\":\"What main requirements are suggested for successful clinical adoption?\",\"answer\":\"Clinical translation requires selective modulation of signaling pathways, restricted activity to defined sites, and precise control of timing, along with addressing long-term safety, manufacturing, regulation, and optimization challenges.\"}]","Theragenerative Nanomaterials: Integrating Therapy, Regeneration, and Diagnosis - Navigating the Shared Pathways Between Tissue Repair and Malignancy | PDF",1790105330,179,[152,156,160,164,168,172,176,180],{"page_no":22,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/44c222a421a0df821f0f268d75ee9bc4.webp",983,1272,{"page_no":26,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9bbac6690b13d4bbc49b9eac49dcb6c0.webp",982,1270,{"page_no":30,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd7c0d1b24e8af414e37704bf78de944.webp",981,1269,{"page_no":33,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/455efe0199e06d7d4478dd13bbcfd800.webp",980,1268,{"page_no":101,"url":169,"width":170,"height":171},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9b4f71b0e0358b625dc524e13932c598.webp",979,1267,{"page_no":106,"url":173,"width":174,"height":175},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed1401322e0b5302d33cf85acbc0a70a.webp",978,1265,{"page_no":111,"url":177,"width":178,"height":179},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59e8d674549ec351973e41d79b60562f.webp",977,1264,{"page_no":116,"url":181,"width":182,"height":183},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4ef11dad73654413c98d69a775fe592.webp",976,1263]